Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: cholesterol depletion

January 27, 2026 CD as API / Pharma applications

A water-soluble β-cyclodextrin polymer reduces cholesterol accumulation and autophagy dysfunction in vitro and in Niemann-Pick type C disease model mice

A β-CDP (CycloLab) was used for the experiments. The purity of the β-CDP was >95 %. The β-CDP contained <1 % of

Continue reading

December 23, 2025 CD as API / CD derivatives / Pharma applications

Multifunctional biomimetic nanocarriers for the treatment of atherosclerosis

Atherosclerosis (AS) has been considered a systemic disease characterized by the excessive generation of reactive oxygen species (ROS) and the

Continue reading

September 8, 2025 Uncategorized

α-CD Derivatives: Low Efficacy and Ototoxicity in NPC Models

HP-β-CD is currently under clinical investigation for treating Niemann-Pick disease type C (NPC), but its ototoxicity remains problematic. It was

Continue reading

June 24, 2025 CD as API / Pharma applications

Cholesterol Depletion by Cyclodextrins Reduces Pain Sensation

The nociceptive Transient Receptor Potential Vanilloid 1 (TRPV1) and Ankyrin 1 (TRPA1) channels are predominantly expressed on peptidergic sensory nerves,

Continue reading

July 15, 2022 Food / Non-pharma applications

β-Cyclodextrin as the Key Issue in Production of Acceptable Low-Cholesterol Dairy Products

The application of cyclodextrins in food technology is extensive due to their unique ability to form complexes with many bioactive

Continue reading

January 26, 2022 CD as API / CD derivatives / Pharma applications

Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis

Cholesterol crystals (CCs), originally accumulating in the lysosome of cholesterol-laden cells, can aggravate the progression of atherosclerosis. β-cyclodextrin (CD) is

Continue reading

November 29, 2021 CD derivatives / Drug delivery / Pharma applications

Synthesis and biological evaluation of novel β-cyclodextrin-fluvastatin conjugates

Drugs that may regulate lipid metabolism and lower cholesterol, such as statins (drugs that reduce de novo cholesterol synthesis) or

Continue reading

October 7, 2021 CD as API / Pharma applications

Visualization of cholesterol depletion at the plasma membrane by methyl-β-cyclodextrin

The most common method to modify cellular cholesterol content in vitro is to incubate cells with cyclodextrin (CD). However, it

Continue reading

April 23, 2020 CD as API

Novel example for the antiviral effect of methyl beta-CD

MβCD was found again to have antiviral effect, but in this case the Chinese scientists found that the cholesterol removal

Continue reading

April 14, 2020 Pharma applications / Uncategorized

Modulation of Plasma Membrane Composition and Microdomain Organization by methyl beta-CD in B16-F10 Mouse Melanoma Cells

The most interesting finding of Crui et al. in their recently published paper [1] for the readers of the Cyclodextrin

Continue reading

Posts pagination

1 2 Next Posts»

Recent Posts

  • 4th International Aquatic Biotechnology Symposium
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution
  • Reviewing Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications
  • Complexation of Citalopram with β-Cyclodextrin, Mono-Subetadex and Subetadex – A Comparison of Analytical Techniques
  • Effect of cyclodextrins on cardiometabolic indices: a systematic review and meta-analysis of randomized controlled trials

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (352)
  • CD derivatives (427)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (806)
  • E-ducation (63)
  • Environmental (143)
  • Events (237)
  • Food (230)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (411)
  • Other industrial use (111)
  • Pharma applications (1,205)
  • Supramolecular systems (44)
  • Uncategorized (163)

Top Posts

  • Reviewing Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications
  • 4th International Aquatic Biotechnology Symposium
  • FDA: Inclusion complex of a GRAS guest and a GRAS host is also GRAS
  • Are cyclodextrins safe for intravitreal injections?
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution
  • Complexation of Citalopram with β-Cyclodextrin, Mono-Subetadex and Subetadex - A Comparison of Analytical Techniques
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Antibody conjugated cyclodextrin for tumor drug delivery
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Impact of Cholesterol Depletion by Methyl BCD on Dopamine Transmission Dynamics in Brain

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...